KITE
Live / Registered — Registered (as of 10 Jan 2023)
What this means for you
Registered since 10 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88315073
- Registration number
- 6950276
- Mark type
- Design + words
- Filed
- 25 Feb 2019
- Published for opposition
- 25 Jun 2019
- Registered
- 10 Jan 2023
- Attorney of record
- Christina L. Martini
Goods and services
- Class 036 — Insurance and financial services: Financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services
- Class 040 — Treatment of materials: Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy
- Class 044 — Medical, beauty and agricultural services: Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory services; collection and preservation of biological tissue, blood and cells
- Class 045 — Legal and security services: Providing patient advocate services in the field of the treatment of diseases and disorders
Owner
- Kite Pharma, Inc., Santa Monica, CA, US
- Kite Pharma, Inc., Santa Monica, CA, US
- Kite Pharma, Inc., Santa Monica, CA, US
Prosecution history
- 10 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 06 Dec 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Dec 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Nov 2022 — ASSIGNED TO EXAMINER
- 19 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Aug 2022 — USE AMENDMENT FILED
- 18 Aug 2022 — TEAS STATEMENT OF USE RECEIVED
- 02 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Feb 2022 — SOU EXTENSION 5 GRANTED
- 24 Jan 2022 — SOU EXTENSION 5 FILED
- 01 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 14 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jul 2021 — SOU EXTENSION 4 GRANTED